These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3124282)

  • 21. Home treatment of mild to moderate bleeding episodes using recombinant factor VIIa (Novoseven) in haemophiliacs with inhibitors.
    Key NS; Aledort LM; Beardsley D; Cooper HA; Davignon G; Ewenstein BM; Gilchrist GS; Gill JC; Glader B; Hoots WK; Kisker CT; Lusher JM; Rosenfield CG; Shapiro AD; Smith H; Taft E
    Thromb Haemost; 1998 Dec; 80(6):912-8. PubMed ID: 9869160
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Coincident classic hemophilia and "idiopathic" thrombocytopenic purpura in patients under treatment with concentrates of antihemophilic factor (factor VIII).
    Ratnoff OD; Menitove JE; Aster RH; Lederman MM
    N Engl J Med; 1983 Feb; 308(8):439-42. PubMed ID: 6401839
    [No Abstract]   [Full Text] [Related]  

  • 23. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The management of musculoskeletal problems in hemophilia. Part I. Principles of medical management of hemophilia.
    McMillan CW; Greene WB; Blatt PM; White GC; Roberts HR
    Instr Course Lect; 1983; 32():210-6. PubMed ID: 6443730
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of the type of factor VIII concentrate on the CD4 lymphocyte count in hemophiliacs with human immunodeficiency virus infection: the results of a meta-analysis].
    Montoro Ronsano JB; Oliveras Martín J; Tusell Puigbert JM
    Med Clin (Barc); 1994 Nov; 103(18):690-4. PubMed ID: 7808075
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Hemophilia. New aspects in diagnosis and treatment].
    Gormsen J
    Ugeskr Laeger; 1973 Nov; 135(46):2487-93. PubMed ID: 4592776
    [No Abstract]   [Full Text] [Related]  

  • 27. [Cellular immunology status in 5 hemophilic patients with inhibitors subjected to massive therapy with factor VIII concentrate].
    Aznar JA; Jorquera JI; González Molina A; Carbonell F; Trenor A; Sánchez Cuenca JM; de Andrés R
    Sangre (Barc); 1983; 28(5):663-4. PubMed ID: 6420915
    [No Abstract]   [Full Text] [Related]  

  • 28. [Proceedings: Therapy of hemophilia A and B].
    Mannucci PM
    Minerva Pediatr; 1973 Dec; 25(42):1889-905. PubMed ID: 4359559
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunological status and HIV antibodies in patients with haemophilia--a longitudinal study.
    Fuchs D; Hausen A; Reibnegger G; Werner ER; Vinazzer H; Dierich MP; Wachter H
    Wien Klin Wochenschr; 1988 Aug; 100(15):505-9. PubMed ID: 3140497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of hemophilia.
    Rodeghiero F
    Ric Clin Lab; 1985; 15(4):289-303. PubMed ID: 3914697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Inhibitors in congenital coagulation disorders.
    Key NS
    Br J Haematol; 2004 Nov; 127(4):379-91. PubMed ID: 15521914
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Specific therapy in hemophilia.
    Hutaff LW
    N C Med J; 1973 Mar; 34(3):193-6. PubMed ID: 4510809
    [No Abstract]   [Full Text] [Related]  

  • 34. [Lymphocyte subpopulations in hemophilia A and B].
    Ollero M; Leal M; Wichman I; García M; Muñoz J; Miranda ML; Jiménez JM; Núñez A; Pascual A; Lissen E
    Med Clin (Barc); 1984 Oct; 83(12):479-81. PubMed ID: 6439957
    [No Abstract]   [Full Text] [Related]  

  • 35. Emergency room care for hemophiliac patients. Understanding and overcoming difficulties.
    J Fla Med Assoc; 1993 Apr; 80(4):250-4. PubMed ID: 8505616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Abnormalities of circulating lymphocyte subsets in haemophiliacs in an AIDS-free population.
    Carr R; Veitch SE; Edmond E; Peutherer JF; Prescott RJ; Steel CM; Ludlam CA
    Lancet; 1984 Jun; 1(8392):1431-4. PubMed ID: 6145879
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of patients with hemophilia A and inhibitors to factor FVIII with cimetidine.
    Ambriz Fernandez R; Quintana Gonzalez S; Martinez Murillo C; Dominguez Garcia V; Rodriguez Moyado H; Collazo Jaloma J
    Arch Med Res; 1996; 27(1):15-8. PubMed ID: 8867361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prospective, randomised trial of two doses of rFVIIa (NovoSeven) in haemophilia patients with inhibitors undergoing surgery.
    Shapiro AD; Gilchrist GS; Hoots WK; Cooper HA; Gastineau DA
    Thromb Haemost; 1998 Nov; 80(5):773-8. PubMed ID: 9843170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The maintenance of tolerance after successful immune tolerance induction in hemophilia A and B: the North American Registry. Factor VIII/IX Subcommittee of the International Society for Thrombosis and Hemostasis.
    DiMichele D; Kroner B;
    Haematologica; 2000 Oct; 85(10 Suppl):40-2; discussion 42-4. PubMed ID: 11187869
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibitors of factor VIII: detection and treatment.
    Brettler DB
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():21-5. PubMed ID: 7886576
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.